Welcome to the 2025 ISPE Annual Conference.

**Please Note: Listed times are for the Eastern Time Zone (ET)**

INSTRUCTIONS

INSTALL ZOOM IN ADVANCE

You will be using Zoom to watch the live stream sessions. For the best experience, you are encouraged to install the desktop application in advance, which you can find by clicking here. A registered Zoom account is NOT required to connect and stream sessions.

ACCESSING INDIVIDUAL SESSIONS

Click on the session that you would like to view. You will be prompted to add your name and email and click “register.” After you click register, if the session has not yet begun, you will see a “holding message” until the sessions starts.

If you need to re-join a session, close Zoom and click again on the session link located on the ISPE webpage. Anytime you join a Zoom session, you will be asked to re-enter your details.

Zoom’s Chat function cannot be used to direct questions to presenters on-site in Berlin. The Chat is purely for attendees connected to the live stream channel.

TECHNICAL ISSUES

If you have any technical difficulties during the session, please visit our support page.

Plenary Session 1

8:00 AM – 10:00 AM ET

Welcome to ISPE 2025 and Keynote Session: Pragmatic Pharmacoepidemiology: Innovative Clinical Evidence Supporting Regulatory Decision-making

Oral Presentations Session 1

10:30 AM – 12:00 PM ET

1A – Comparative safety and effectiveness in cardio/renal/metabolic diseases

10:30 AM – 12:00 PM ET

1B – COVID-19 and recovery

10:30 AM – 12:00 PM ET

1C – Maternity Medley

10:30 AM – 12:00 PM ET

1D – Non-Covid Vaccines: Protecting Health and Building Trusts

10:30 AM – 12:00 PM ET

1E – Safer drugs for mental illness and addiction

10:30 AM – 12:00 PM ET

1F – The algorithm awakens: pregancy and data

10:30 AM – 12:00 PM ET

1G – To err is not only human

Symposia & Workshops: Session 1

1:30 PM – 3:00 PM ET

SW-1A – Building transparency and reproducibility into the practice of pharmacoepidemiology and outcomes research

1:30 PM – 3:00 PM ET

SW-1B – Bridging Real-world and RCT Endpoints: Mitigating Measurement Error Bias in Time-to-event Endpoints in Studies using Oncology Real-world Data

1:30 PM – 3:00 PM ET

SW-1C – Consolidated Multi-product/Disease-based Pregnancy Exposure Registries: How to Encourage Collaboration in a Fragmented Environment?

1:30 PM – 3:00 PM ET

SW-1D – What are possible approaches when the active comparator new users design (ACNU) is not easily applicable?

1:30 PM – 3:00 PM ET

SW-1E – Advances in Pharmacoepidemiology in Africa: The African Regional Interest Group Experience

1:30 PM – 3:00 PM ET

SW-1F – Integrating Real-World Data with Randomized Controlled Trials: Advancing Evidence Generation

1:30 PM – 3:00 PM ET

SW-1G – What can pharmacoepidemiologists do to enhance vaccine confidence?

Oral Presentations: Session 2

3:30 PM – 5:00 PM ET

2A – A Dose of Disparity: Measuring Inequality in Healthcare

3:30 PM – 5:00 PM ET

2B – A fine assortment of drug safety talks

3:30 PM – 5:00 PM ET

2C – Innovative Methods and Designs in Vaccine Research: Advancing Precision and Impact

3:30 PM – 5:00 PM ET

2D – Lightning Session 1

3:30 PM – 5:00 PM ET

2E – Methods mixer

3:30 PM – 5:00 PM ET

2F – Mining expeditions

3:30 PM – 5:00 PM ET

2G – Navigating the Neurochemical Journey in Pregnancy

Symposia & Workshops: Session 2

5:15 PM – 6:45 PM ET

SW-2A – Real-World Evidence in Regulatory Decision-Making for Medical Products

5:15 PM – 6:45 PM ET

SW-2B – The Clone-Censor-Weight Approach: From Basic Principles to Its Transformation in Diverse Exposure and Outcome Scenarios

5:15 PM – 6:45 PM ET

SW-2C – Dynamic Modeling of Medication Adherence: A Hands-on Exploration of Trajectory Analysis Techniques

5:15 PM – 6:45 PM ET

SW-2D – The Future of Pharmacovigilance: Accelerating Signal Identification With Electronic Healthcare Data

5:15 PM – 6:45 PM ET

SW-2E – Resolved That the Hierarchy of Evidence Should Be Replaced: A Debate

5:15 PM – 6:45 PM ET

SW-2F – Overcoming Challenges in CDM Harmonization from Within-Country Coordination to International Collaboration

5:15 PM – 6:45 PM ET

SW-2G – Addressing the threat of confounding in pharmacoepidemiology with innovative methods: Lessons from the FDA Sentinel Innovation Center

Oral Presentations: Session 3

8:15 AM – 9:45 AM ET

3A – Drug effectiveness from head-to-toe

8:15 AM – 9:45 AM ET

3B – Keep pumping: cardiovascular and respiratory drug safety

8:15 AM – 9:45 AM ET

3C – Lightning Session 2

8:15 AM – 9:45 AM ET

3D – Machines make it easier

8:15 AM – 9:45 AM ET

3E – Metabolic risk and cardiovascular disease

8:15 AM – 9:45 AM ET

3F – Older Adults Are All Heart

8:15 AM – 9:45 AM ET

3G – Trial & Triumph: Targeting Success in Pregnancy Studies

Plenary Session 2

10:15 AM – 11:30 AM ET

Plenary: Burdens of Proof in the Pharmaceutical Century

Symposia & Workshops: Session 3

1:00 PM – 2:30 PM ET

SW-3A – Navigating Around Quicksand: Mapping the Complexities of Externally Controlled Trial (ECT) Designs

1:00 PM – 2:30 PM ET

SW-3B – Developing Computable Phenotypes for Medical Product Safety Surveillance: Innovative Methods and Data Sources

1:00 PM – 2:30 PM ET

SW-3C – How should we interpret self-controlled study designs in the era of causal inference?

1:00 PM – 2:30 PM ET

SW-3D – Real World Evidence generation in Low and Middle Income Countries for vaccines

1:00 PM – 2:30 PM ET

SW-3E – Advances in Medical Device RWE Use for Label Expansions and National Coverage Decisions

1:00 PM – 2:30 PM ET

SW-3F – Introduction to R Shiny for Pharmacoepidemiologists: Interactive Visualization in Real-World Evidence Studies

1:00 PM – 2:30 PM ET

SW-3G – Precision Medicine and Pharmacoepidemiology Synergistic Approaches to Real-World Evidence

Plenary Session 3

2:50 PM – 4:00 PM ET

AGM & Awards Ceremony

Oral Presentations: Session 4

4:15 PM – 5:45 PM ET

4A – A Cohort is a Cohort: Utility for Pharmacovigilance

4:15 PM – 5:45 PM ET

4B – Can cancer treatment be safer?

4:15 PM – 5:45 PM ET

4C – Chronic drugs for chronic illness

4:15 PM – 5:45 PM ET

4D – High-value Outcomes

4:15 PM – 5:45 PM ET

4E – Monumental Evidence: Foundations for Benefit/Risk Decision-Making

4:15 PM – 5:45 PM ET

4F – Pediatrics: Growth and Development, the Brain and the Body

4:15 PM – 5:45 PM ET

4G – PS…are you still there?

Oral Presentations: Session 5

8:30 AM – 10:00 AM ET

5A – Addicted to pharmacoepidemiology

8:30 AM – 10:00 AM ET

5B – Clone wars

8:30 AM – 10:00 AM ET

5C – Covid-19 Vaccine Safety: Science, Facts, and Public Health

8:30 AM – 10:00 AM ET

5D – Disproportionality Proportionate: Pharmacovigilance Methods

8:30 AM – 10:00 AM ET

5E – The safety dance: drugs for obesity and metabolic disorders

8:30 AM – 10:00 AM ET

5F – Use and Safety of Biologics

8:30 AM – 10:00 AM ET

5G – What a Mess: the Environment, Health, and Medications

Symposia & Workshops: Session 4

10:30 AM – 12:00 PM ET

SW-4A – Harnessing Real-world Evidence to Address Drug Shortages

10:30 AM – 12:00 PM ET

SW-4B – Real-world evidence fit for regulatory applications — what does good look like?

10:30 AM – 12:00 PM ET

SW-4C – Environmental Challenges to Supply Chains and Drug Shortages

10:30 AM – 12:00 PM ET

SW-4D – Why Treatment Strategies are a Sine Qua Non of the Causal Estimand

10:30 AM – 12:00 PM ET

SW-4E – Use of Artificial Intelligence/Machine Learning Methods for Identification of Patients with Rare Diseases in Real-World Data

10:30 AM – 12:00 PM ET

SW-4F – Approaches to Time-Zero and Time-Related Bias in External Control Arm Study Design: Methodological Considerations and Applications

10:30 AM – 12:00 PM ET

SW-4G – Seeking the roadmap: Incorporating menstruation and menopause into pharmacoepidemiology research

Oral Presentations: Session 6

1:30 PM – 3:00 PM ET

6A – Aging, Meds, and Modern Challenges: Navigating the Multiverse of Care for Older Adult

1:30 PM – 3:00 PM ET

6B – Cracking the Code in Pregnancy Studies

1:30 PM – 3:00 PM ET

6C – Drug Effectiveness in veterans and friends

1:30 PM – 3:00 PM ET

6D – Lightning Session 3

1:30 PM – 3:00 PM ET

6E – One size fits none: unravelling treatment heterogeneity

1:30 PM – 3:00 PM ET

6F – Perfect timing

1:30 PM – 3:00 PM ET

6G – The target stands trial

Plenary Session 4

3:15 PM – 4:15 PM ET

Hot Topic Debate: Large Language Models and AI in Pharmacoepidemiology: Job tool or job takeover?

3:45 PM – 5:00 PM ET

The Final Word